A Health Technology Assessment of a breakthrough technology in the early diagnosis of Osteoporosis and other bone related diseases.

The Porous solution aims to revolutionize osteoporosis diagnosis by using mobile ultrasound technology to assess cortical bone quality and fracture risk more effectively than current BMD methods.

Subsidie
€ 2.500.000
2023

Projectdetails

Introduction

Osteoporosis accounts for more days in the hospital than breast cancer, heart attack, and diabetes, leading to huge healthcare costs. Despite this, bone mineral density (BMD), the current gold standard for diagnosis of osteoporosis, is insufficient and fails to detect 80% of people at risk of a fragility fracture.

The Porous Solution

The Porous solution aims to replace BMD as the standard for osteoporosis diagnosis.

Technology Overview

Using mobile and harmless quantitative ultrasound technology with our patented intelligent algorithms, we can for the first time measure the cortical bone quality down to the microscopic pore level. This gives a multifactorial analysis of fracture risk that overcomes the weaknesses of BMD.

Accessibility and Impact

Due to the use of mobile ultrasound systems, this solution can be used anywhere in or outside the hospital, such as primary care facilities.

  1. It creates the ability to use the technology for prevention via screening.
  2. It opens unprecedented possibilities for the early diagnosis of osteoporosis.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.500.000
Totale projectbegroting€ 3.730.018

Tijdlijn

Startdatum1-2-2023
Einddatum30-4-2025
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • POROUS GMBHpenvoerder

Land(en)

Germany

Vergelijkbare projecten binnen EIC Accelerator

EIC Accelerator

Drug solution for bone fracture nonunions

Genera Research aims to develop OSTEOGROW-C, a novel biological drug using patients' blood to treat bone fracture nonunion, promising effective regeneration and reduced complications.

€ 2.499.999
EIC Accelerator

Clinical validation of the First Implantable Sensor System for Wireless detection of stent occlusion/ restenosis

VesselSens is developing StentGuard, a smart device for early, non-invasive detection of restenosis in PAD patients to improve outcomes and reduce healthcare costs.

€ 2.500.000

Vergelijkbare projecten uit andere regelingen

EIC Pathfinder

Live Cell Spectroscopy Analysis for Personalised Particle Radiation Therapy of Metastatic Bone Cancer

BoneOscopy aims to revolutionize metastatic bone cancer treatment by enabling daily monitoring during particle radiotherapy, enhancing personalized care and treatment efficacy.

€ 3.069.321
Mkb-innovati...

Booropzetstuk voor bot mineraal dichtheid meting tijdens behandeling van fracturen

SLAM Ortho onderzoekt de haalbaarheid van een booropzetstuk voor real-time meting van botmineraaldichtheid, wat chirurgen helpt bij fractuurbehandeling en vroegtijdige osteoporose-diagnose.

€ 20.000
ERC Starting...

Advanced analysis of multiparametric volumetric ultrafast ultrasound: a novel approach for non-invasive breast cancer diagnosis

This project aims to enhance non-invasive breast cancer diagnosis by integrating machine learning with advanced ultrasound techniques to create predictive models for tumor characteristics, reducing reliance on biopsies.

€ 1.499.498
ERC Advanced...

Healthy Microbiota Avoiding Fractures during Ageing

This project aims to identify gut microbiota signatures linked to age-related bone and muscle loss to develop novel fracture prevention therapies for the elderly.

€ 2.499.993
ERC Proof of...

Development of patient “Ossicle” for the personalized modelling of bone-developing cancers and therapeutic testing

OssiGel aims to standardize the formation of human mini-bones in mice for studying bone-developing cancers and testing personalized therapeutics effectively.

€ 150.000